Newly Activated Clinical Trials

This is a listing of clinical trials recently activated by the University of Illinois Cancer Center Clinical Trials Office for patient enrollment. Click the study links below to learn details regarding the studies on clinicaltrials.gov. You can also search for other clinical trials on our website. For more information or questions about a study, email [email protected] or call 312-355-5112.


Protocol Title: HCRN-GI23-643: Randomized trial of Regorafenib in Combination with Pembrolizumab or Pembrolizumab Monotherapy for Patients with MSI-H Colorectal Cancer

Sponsors: Hoosier Cancer Research Network

Principal Investigator: Shikha Jain, MD, FACP

Photo of Shikha Jain

Protocol Title: A032201: Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma – STRIKE

Sponsors: Alliance

Investigator: Karine Tawagi, MD

Headshot of Karine Tawagi, MD
Translate »